Akums Drugs & Pharma acquires new formulation facility in Baddi
Himachal Pradesh: Akums Drugs & Pharmaceuticals has said it has acquired a new formulation facility located in Baddi, Himachal Pradesh.
The plant, which is spread across six acres, is currently undergoing upgrades and is slated to become operational next year.
Once operational, the plant would cater to the oral solid dosage segment, significantly enhancing the company's tablet manufacturing capacity.
"The acquisition of the Baddi facility serves as a clear indicator of our company's planned foresight and proactive approach in contributing to market dynamics," Akums joint managing director Sanjeev Jain said in a statement.
As the industry undergoes substantial growth, the company's objective is to contribute not only to the Indian market but also attempt to leave a lasting imprint on the international stage, he added.
"Once operational, the Baddi facility will play a significant role in augmenting our manufacturing capabilities, allowing us to efficiently address the various needs of our clients," Jain noted.
Akums caters to clients across pharma, nutraceutical and fast-moving consumer goods sectors.
Read also: Akum Pharmaceutical Gets CDSCO Panel Nod to Manufacture, Market Azelnidipine, Metoprolol FDC tablet
Akums Drugs & Pharmaceuticals Ltd. is a contract-manufacturing pharmaceutical company of India. The organization deals in the manufacturing and export of formulations in a wide spectrum of dosage forms & therapeutic segments. The company is currently supplying to almost all Indian and multinational pharmaceutical companies across the globe. The 10 state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (Injectable, eye, ear & nasal), hormonal (oral and injectable), Ointments & cosmetics, Ayurvedic, food supplements & nutraceuticals and animal health care.
The organization is certified with WHO-GMP, ISO 9001 : 2008, ISO 14001:2004 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi amongst others.
Read also: Akums Pharma gets CDSCO panel nod To Manufacture, Market FDC of doxylamine and pyridoxine
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.